Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Danaher Corporation    DHR   US2358511028

SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 

DANAHER CORP. : Danaher to Present at Deutsche Bank Industrials Conference

06/16/2010 | 04:05pm US/Eastern
Recommend:
0

WASHINGTON, June 16 /PRNewswire-FirstCall/ -- Danaher Corporation (NYSE: DHR) announced that Executive Vice President and Chief Financial Officer, Daniel L. Comas will be presenting at the Deutsche Bank Industrials Conference in Chicago, Illinois on Wednesday, June 23 at 2:25 p.m. EDT. The audio will be simultaneously webcast on www.danaher.com. The presentation will be archived on www.danaher.com for one week.

Danaher (NYSE: DHR), based in Washington. D.C., is a diversified technology leader that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. Our portfolio of premier brands is among the most highly recognized in each of the markets we serve. Driven by strong core values and a foundation provided by the Danaher Business System, our 47,000 associates serve customers in more than 125 countries and generated $11.2 billion of revenue in 2009. For more information please visit our website: www.danaher.com.

SOURCE Danaher Corporation

Recommend :
0
React to this article
Latest news on DANAHER CORPORATION
1d ago DANAHER : to Acquire Nobel Biocare Holding AG for CHF 17.10 per share
2d ago DANAHER : Pantone owner danaher buys nobel
3d ago DANAHER : DE/ : Change in Directors or Principal Officers, Financial Statements ..
3d agoDJEUROPE MARKETS : SABMiller Rallies; TDC Slumps: Europe's Big Stock Moves
3d agoDJEUROPE MARKETS : SABMiller Rallies; TDC Slumps: Europe's Big Stock Moves
3d agoDJU.S. HOT STOCKS : Hot Stocks to Watch
3d agoDJEUROPE MARKETS : SABMiller Rallies; TDC Slumps: Europe's Big Stock Moves
3d ago Danaher to buy Nobel Biocare for $2.2 billion
3d ago Danaher to buy Nobel Biocare for $2.2 billion
3d ago NOBEL BIOCARE : Danaher buying Nobel Biocare for about $2.2B
Dynamic quotes  
ON
| OFF